Description
PAXLOVID is a medicine that has two different tablets; one containing the active ingredient, nirmatrelvir and the other containing the active ingredient, ritonavir. PAXLOVID is used to treat COVID-19 in adults who are at increased risk of progression to hospitalisation or death.
PAXLOVID can now be purchased from New Zealand pharmacies under private supply. This provides a COVID-19 treatment option for the following groups of people, where clinically appropriate*:
- Kiwis who do not meet Pharmac's access criteria but may still benefit from treatment
- Kiwis planning to travel overseas
- Non-residents, including people travelling to New Zealand
- Others who wish to purchase PAXLOVID in advance as a precautionary measure
*PAXLOVID is indicated for the treatment of COVID-19 in adults 18 years of age and older, who do not require supplemental oxygen due to COVID-19 and are at increased risk of progression to hospitalisation or death.
Directions
As instructed by your healthcare professional or refer to the Consumer Medicine Information.
Ingredients
Each Nirmatrelvir tablet contains:
Nirmatrelvir 150mg
Excipients: Microcrystalline cellulose, Lactose monohydrate, Croscarmellose sodium, Colloidal anhydrous silica, Sodium stearylfumarate, Opadry Complete Film Coating System 05B140011 Pink.
Each Ritonavir tablet contains:
Ritonavir 100mg
Excipients: Copovidone, Calcium hydrogen phosphate, Sorbitan monolaurate, Colloidal anhydrous silica, Sodium stearylfumarate, Hypromellose, Titanium dioxide, Macrogol 400, Hyprolose, Purified talc, Macrogol 3350, Colloidal anhydrous silica, Polysorbate 80.
Warnings
Store below 25°C.
Do not take if you have ever had an allergic reaction to PAXLOVID or any of the ingredients listed.
General Safety Information
- Always read the label. Use only as directed.
- Nutritional supplements may only be of assistance if the dietary intake is inadequate.
- Supplements should not be used to replace a healthy balanced diet and adequate physical exercise.
- Keep all medications and supplements out of reach of children.
- If symptoms persist see your healthcare professional.